HonorG : GlycoMimetics Shares Are Trading Higher After the Company Announced It Will Merge With Crescent Biopharma and Secured $200 in Funding to Advance Its Oncology Pipeline.
HonorG : GlycoMimetics Shares Are Trading Higher After the Company Announced It Will Merge With Crescent Biopharma and Secured $200 in Funding to Advance Its Oncology Pipeline.